About PNB Vesper
PNB Vesper is a Healthcare company based in Kochi (India) founded in 2011. Therapies for pain, cancer, inflammation, and neurological disorders are developed. PNB Vesper has raised $918.51 thousand across 1 funding round. Its chief executive, as recorded, is Padinjarethalakkal Nanu Ezhuthassan Balaram. Its Indian entity Pnb Vesper Life Science Private Limited reported revenue of ₹9.2 Lakh. Its focus areas include Life Sciences, Immunology, Drugs and Inflammatory Diseases.
Company details
Founded in 2011 in Kochi, India, therapies are developed by PNB Vesper for pain, cancer, inflammation, and neurological disorders in the biotechnology sector. Operations focus on drug candidates targeting gastrointestinal and oncology conditions. The lead product, PNB-001, a CCK2 antagonist, has completed phase I trials for IBSIBD and inflammatory pain. Additional candidates, PNB-028 and PNB-081, address pancreatic cancer, pancreatitis, and pain management.
- Headquarters Kochi, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pnbvesper.com
- Social LinkedIn X Facebook
- Legal Name Pnb Vesper Life Science Private Limited
- Date of Incorporation 13 May, 2011
- Jurisdiction Kochi, Kerala, India
- Annual Revenue₹9.2 Lakh
FY 2024 · +168% YoY
- Net Loss-₹13.7 Lakh
FY 2024 · -150% margin
- EBITDA-₹13.1 Lakh
FY 2024 · -144% margin
- Total Equity Funding$918.51K (USD)
in 1 rounds
- Latest Funding Round$918.51K (USD), Seed
Mar 2013
Associated legal entities of PNB Vesper
PNB Vesper operates through Pnb Vesper Life Science Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pnb Vesper Life Science Private Limited CIN U73100KL2011PTC028397 | Active | 13 May 2011 | Kochi, Kerala | ₹0.1 Cr | 3 | View details |
Funding Insights of PNB Vesper
PNB Vesper has successfully raised a total of $918.51K through 1 strategic funding round. The most recent funding activity was a Seed round of $918.51 thousand completed in March 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $918,505
- Total Rounds 1
- Last Round Seed — $918,505
- First Round $918,505
(Mar 2013)
All 1 funding rounds of PNB Vesper with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2013 | $918,505 | Seed | – | – | – |
Board of directors of Pnb Vesper Life Science Private Limited (PNB Vesper)
Pnb Vesper Life Science Private Limited is the primary company behind PNB Vesper. The board of Pnb Vesper Life Science Private Limited currently have 3 directors; the longest-serving is Padinjarethalakkal Nanu Ezhuthassan Balaram, appointed in 2011. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Padinjarethalakkal Nanu Ezhuthassan Balaram DIN 01665424 | Managing Director | 13 May 2011 | 15 yrs 5 mo | Pnb Vesper Life Science Private Limited |
| Kalathil Sadasivan Pillai DIN 01911145 | Director | 30 Jan 2013 | 13 yrs 9 mo | Pnb Vesper Life Science Private Limited |
| Navaneeth Vishnu DIN 08487267 | Director | 24 Sep 2019 | 7 yrs 1 mo | Pnb Vesper Life Science Private Limited |
People of PNB Vesper
1 people are tracked at PNB Vesper (1 in leadership).
| Name | Role | Group |
|---|---|---|
| CEO & MD | Leadership |
Complete people profiles for PNB Vesper
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of PNB Vesper
Figures of Pnb Vesper Life Science Private Limited, the primary company behind PNB Vesper, for FY 2024. Revenue was ₹9.2 Lakh (+168% year on year). Net loss was -₹13.7 Lakh (-150% margin). EBITDA was -₹13.1 Lakh (-144% margin). Revenue has grown at a compounded annual rate of +89% over three years and +53% over five years.
- ₹9.2 LakhRevenue · FY 2024 · +168% YoY
- -₹13.7 LakhNet loss · -150% margin
- -₹13.1 LakhEBITDA · -144% margin
- ₹5.12 CrPaid-up capital
- +89%Revenue CAGR, 3 years
- +53%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pnb Vesper Life Science Private Limited are on its company page.
Detailed financial statements for PNB Vesper
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of PNB Vesper
2 dated milestones of PNB Vesper across 2 years, from founding to its latest funding, stage changes and deals.
- Founded PNB Vesper is founded.
- Funding First funding round of $919K.
Web traffic of PNB Vesper
The website of PNB Vesper (pnbvesper.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 98.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pnb Vesper
Complete news archive for PNB Vesper
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PNB Vesper
PNB Vesper was founded in 2011 and raised its 1st funding round 2 years after it was founded.
PNB Vesper is headquartered in Kochi, India. It is registered at Kochi, Kerala, India.
Padinjarethalakkal Nanu Ezhuthassan Balaram is the CEO of PNB Vesper, as recorded in our data.
PNB Vesper is a funded company, having raised a total of $918.51K across 1 funding round to date. The company's 1st funding round was a Seed of $918.51K, raised on Mar 2013.
The primary company behind PNB Vesper, Pnb Vesper Life Science Private Limited, reported revenue of ₹9.2 Lakh for FY 2024, up 168% year on year.
Founded in 2011 in Kochi, India, therapies are developed by PNB Vesper for pain, cancer, inflammation, and neurological disorders in the biotechnology sector. Operations focus on drug candidates targeting gastrointestinal and oncology conditions. The lead product, PNB-001, a CCK2 antagonist, has completed phase I trials for IBSIBD and inflammatory pain. Additional candidates, PNB-028 and PNB-081, address pancreatic cancer, pancreatitis, and pain management.
PNB Vesper operates through Pnb Vesper Life Science Private Limited.
The legal entities of PNB Vesper currently have 3 directors, including Kalathil Sadasivan Pillai, Padinjarethalakkal Nanu Ezhuthassan Balaram, Navaneeth Vishnu.